New drug combo tested in battle against bone marrow cancer
NCT ID NCT04268498
Summary
This study is testing whether adding a drug called daratumumab to a three-drug combination works better for controlling newly diagnosed multiple myeloma. Researchers want to see if this four-drug combination is safer and more effective than the standard three-drug treatment. The trial involves 310 adults with newly diagnosed multiple myeloma who haven't had much previous treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huntsman Cancer Institue
Salt Lake City, Utah, 84113, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612-9497, United States
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14203, United States
-
Stony Brook University
Stony Brook, New York, 11794, United States
-
University of Miami
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.